Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 9, 2019
Distinct Roles of Direct Transduction Versus Exposure to the Tumor Secretome on Murine Endothelial Cells After Melanoma Gene Therapy with Interferon-β and p19Arf
Igor de Luna Vieira, Rodrigo Esaki Tamura, Aline Hunger, et al.
Gene Therapy
|
March 31, 2019
Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth
Rodrigo Esaki Tamura, Marlous G Lana, Eugenia Costanzi-Strauss, et al.
Human Vaccines & Immunotherapeutics
|
January 7, 2017
Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials
João Paulo Portela Catani, Rachel P Riechelmann, Sandy Adjemian, et al.
Oncoimmunology
|
August 17, 2017
Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death
Ruan F V Medrano, Aline Hunger, João P P Catani, et al.
Clinics (Sao Paulo, Brazil)
|
August 23, 2018
Improving adenoviral vectors and strategies for prostate cancer gene therapy
Rodrigo Esaki Tamura, Igor Vieira de Luna, Marlous Gomes Lana, et al.
Cancer Biology & Therapy
|
September 21, 2016
Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy
Rodrigo Esaki Tamura, Rafael Bento da Silva Soares, Eugenia Costanzi-Strauss, et al.
Biochemical and Biophysical Research Communications
|
August 22, 2006
A lentiviral vector with expression controlled by E2F-1: a potential tool for the study and treatment of proliferative diseases
Bryan E Strauss, Juliana Rotelli Patrício, Anna Carolina Vieira de Carvalho, et al.
Virology
|
November 12, 2013
AAVPG: a vigilant vector where transgene expression is induced by p53
Marcio C Bajgelman, Ruan F V Medrano, Anna Carolina P V Carvalho, et al.
Oncotarget
|
October 21, 2017
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
Ruan F V Medrano, Aline Hunger, Samir Andrade Mendonça, et al.
Molecular Therapy. Methods & Clinical Development
|
June 9, 2015
Genetic barcode sequencing for screening altered population dynamics of hematopoietic stem cells transduced with lentivirus
Daniela B Zanatta, Maristela Tsujita, Primavera Borelli, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 9, 2019
Distinct Roles of Direct Transduction Versus Exposure to the Tumor Secretome on Murine Endothelial Cells After Melanoma Gene Therapy with Interferon-β and p19Arf
Igor de Luna Vieira, Rodrigo Esaki Tamura, Aline Hunger, et al.
Gene Therapy
|
March 31, 2019
Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth
Rodrigo Esaki Tamura, Marlous G Lana, Eugenia Costanzi-Strauss, et al.
Human Vaccines & Immunotherapeutics
|
January 7, 2017
Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials
João Paulo Portela Catani, Rachel P Riechelmann, Sandy Adjemian, et al.
Oncoimmunology
|
August 17, 2017
Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death
Ruan F V Medrano, Aline Hunger, João P P Catani, et al.
Clinics (Sao Paulo, Brazil)
|
August 23, 2018
Improving adenoviral vectors and strategies for prostate cancer gene therapy
Rodrigo Esaki Tamura, Igor Vieira de Luna, Marlous Gomes Lana, et al.
Cancer Biology & Therapy
|
September 21, 2016
Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy
Rodrigo Esaki Tamura, Rafael Bento da Silva Soares, Eugenia Costanzi-Strauss, et al.
Biochemical and Biophysical Research Communications
|
August 22, 2006
A lentiviral vector with expression controlled by E2F-1: a potential tool for the study and treatment of proliferative diseases
Bryan E Strauss, Juliana Rotelli Patrício, Anna Carolina Vieira de Carvalho, et al.
Virology
|
November 12, 2013
AAVPG: a vigilant vector where transgene expression is induced by p53
Marcio C Bajgelman, Ruan F V Medrano, Anna Carolina P V Carvalho, et al.
Oncotarget
|
October 21, 2017
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
Ruan F V Medrano, Aline Hunger, Samir Andrade Mendonça, et al.
Molecular Therapy. Methods & Clinical Development
|
June 9, 2015
Genetic barcode sequencing for screening altered population dynamics of hematopoietic stem cells transduced with lentivirus
Daniela B Zanatta, Maristela Tsujita, Primavera Borelli, et al.
Page
of 6